RESPONSE TO T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BM)

被引：0

作者：

Berghoff, A. S. ^{[1
]}

Bartsch, R. ^{[1
]}

Bergen, E. ^{[1
]}

Rudas, M. ^{[2
]}

Gnant, M. ^{[3
]}

Dieckmann, K. ^{[4
]}

Pinker, K. ^{[5
]}

Zielinski, C. C. ^{[1
]}

Steger, G. G. ^{[1
]}

Preusser, M. ^{[1
]}

机构：

[1] Med Univ Vienna, Dept Med 1, Clin Div Oncol, Vienna, Austria

[2] Med Univ Vienna, Dept Pathol, Vienna, Austria

[3] Med Univ Vienna, Dept Surg, Vienna, Austria

[4] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria

[5] Med Univ Vienna, Dept Radiol, Vienna, Austria

来源：

NEURO-ONCOLOGY | 2014年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P08.01

引用

页数：1

共 50 条

[41] Radio-sensitising effect of T-DM1 should not be discarded for the efficacy of radiosurgery in the management of brain metastases in patients with HER2-positive metastatic breast cancer
Kadri Altundag
Journal of Neuro-Oncology, 2017, 132 : 525 - 525
[42] Exposure-Response Relationship of T-DM1: Insight Into Dose Optimization for Patients With HER2-Positive Metastatic Breast Cancer
Wang, J.
Song, P.
Schrieber, S.
Liu, Q.
Xu, Q.
Blumenthal, G.
Kordestani, L. Amiri
Cortazar, P.
Ibrahim, A.
Justice, R.
Wang, Y.
Tang, S.
Booth, B.
Mehrotra, N.
Rahman, A.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (05) : 558 - 564
[43] HER2DX genomic assay in advanced HER2-positive (HER2+) breast cancer treated with T-DM1
Braso-Maristany, F.
Griguolo, G.
Chic, N.
Pare Brunet, L.
Galvan, P.
Dieci, M. V.
Miglietta, F.
Giarratano, T.
Martinez-Saez, O.
Marin, M.
Vidal Losada, M. J.
Adamo, B.
Munoz, M.
Vivancos, A.
Villagrasa Gonzalez, P.
Parker, J.
Perou, C. M.
Conte, P. F.
Prat, A.
Guarneri, V.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S646 - S646
[44] Radio-sensitising effect of T-DM1 should not be discarded for the efficacy of radiosurgery in the management of brain metastases in patients with HER2-positive metastatic breast cancer
Altundag, Kadri
JOURNAL OF NEURO-ONCOLOGY, 2017, 132 (03) : 525 - 525
[45] The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells
Peipei Liu
Jiajun Fan
Ziyu Wang
Wenjing Zai
Ping Song
Yongping Li
Dianwen Ju
AMB Express, 10
[46] ERBB2mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer
Griguolo, Gaia
Braso-Maristany, Fara
Gonzalez-Farre, Blanca
Pascual, Tomas
Chic, Nuria
Sauri, Tamara
Kates, Ronald
Gluz, Oleg
Martinez, Debora
Pare, Laia
Tsvetkova, Vassilena
Pesantez, David
Vidal, Maria
Adamo, Barbara
Munoz, Montserrat
Galvan, Patricia
Barbera, Laura
Cuatrecasas, Miriam
Christgen, Mathias
Kreipe, Hans
Monge-Escartin, Ines
Villagrasa, Patricia
Soy, Dolors
Giarratano, Tommaso
Dieci, Maria Vittoria
Conte, Pierfranco
Harbeck, Nadia
Guarneri, Valentina
Prat, Aleix
CANCERS, 2020, 12 (07) : 1 - 25
[47] In vitro effects of Trastuzumab Emtansine (T-DM1) and concurrent irradiation on HER2-positive breast cancer cells
Mignot, F.
Kirova, Y.
Verrelle, P.
Teulade-Fichou, M-P
Megnin-Chanet, F.
CANCER RADIOTHERAPIE, 2021, 25 (02): : 126 - 134
[48] Trastuzumab emtansine (T-DM1) as adjuvant treatment of HER2-positive early breast cancer: safety and efficacy
Molinelli, Chiara
Parisi, Francesca
Razeti, Maria Grazia
Arecco, Luca
Cosso, Maurizio
Fregatti, Piero
Del Mastro, Lucia
Poggio, Francesca
Lambertini, Matteo
EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (03) : 241 - 250
[49] The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells
Liu, Peipei
Fan, Jiajun
Wang, Ziyu
Zai, Wenjing
Song, Ping
Li, Yongping
Ju, Dianwen
AMB EXPRESS, 2020, 10 (01)
[50] Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer
Ponde, Noam
Ameye, Lieveke
Lambertini, Matteo
Paesmans, Marianne
Piccart, Martine
de Azambuja, Evandro
EUROPEAN JOURNAL OF CANCER, 2020, 126 : 65 - 73

← 1 2 3 4 5 →